Extended Data Fig. 4: Depth of pathologic response (%RVT) in the PT of path-evaluable patients receiving nivolumab plus chemotherapy.
From: Association between pathologic response and survival after neoadjuvant therapy in lung cancer
The optimal value for %RVT (5% RVT) was calculated from the receiver operating characteristic curve analysis using the Youden’s index (that maximizes the true positive rate and minimizes the false positive rate). PT denotes primary tumor; RVT, residual viable tumor.
